Early Regulations are Shaping the Future of Canadian Cannabis

Early Regulations are Shaping the Future of Canadian Cannabis
Early Regulations are Shaping the Future of Canadian Cannabis

NetworkNewsWire Editorial Coverage: 

North American cannabis markets have achieved tremendous growth in recent years, and that trend shows no sign of slowing down. Cannabis research firm ArcView has called for an annualized growth rate of 26 percent through 2021, as the burgeoning industry benefits from growing popular support and regulatory changes. Perhaps the most notable of these pending amendments is Canada's planned nationwide legalization of recreational cannabis. Canadian Health Minister Ginette Peitipas Taylor has stoked optimism regarding an August or September 2018 official launch date for recreational cannabis across Canada. 

Choom Holdings, Inc. (OTC: CHOOF) (CSE: CHOO), with its growing portfolio of four late-stage licensed producer applicants, is primed to pounce on this new market opportunity. Through an aggressive acquisition strategy and strong commitment to developing national retail distribution, Choom has quickly positioned itself as a major player among other North American cannabis industry mainstays like Cronos Group, Inc. (TSX-V: CRON) (NASDAQ: CRON), Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF), Aphria, Inc. (TSX: APH) (OTC: APHQF) and Hiku Brands Company, Ltd. (CSE: HIKU) (OTC: DJACF).

An Evolving Regulatory Landscape

Canada's quest to become the first G7 nation to legalize recreational marijuana comes with a number of logistical and regulatory challenges (http://nnw.fm/zfk3U). Two of the most prominent in the nascent industry have related to licensing, both for growers and retailers. Canadian cultivators are currently subject to the Access to Cannabis for Medical Purposes Regulations (ACMPR). Implemented in 2016, the ACMPR places the administration of Canada'scannabis cultivation industry in the hands of Health Canada, the federal department tasked with responsibility for national public health. Currently, only producers who are licensed under the ACMPR may sell or provide dried marijuana, fresh marijuana, cannabis oil or starting materials. With the number of licensed producers limited on a provincial basis, ACMPR approval marks a significant milestone in the development of all Canadian cannabis producers.

Licensing for the sale of recreational cannabis, on the other hand, has been tasked to individual provinces. With full-scale legalization rapidly approaching, multiple provinces have already begun awarding licenses for the sale of recreational cannabis, including Manitoba and Saskatchewan (http://nnw.fm/axi7A. Much like ACMPR approval has proven to be a 'make or break' retail license achievement for cannabis firms. Companies that successfully position themselves to secure these early retail permits figure to have a key strategic advantage in the supply and sale of products directly to consumers through retail outlets.

Riding the Wave

The Choom Holdings, Inc. (OTCQB: CHOOF) (CSE: CHOO) team is well accustomed to navigating the tides of change on its way to fields of green. The company prides itself on its ability to channel the laid-back spirit of Hawaii without missing out on the opportunities presented by the changing marijuana markets of North America. In total, the company Choom™ has acquired two ACMPR applicants and has agreements in place to acquire two additional ACMPR applicants, including its most recent addition (http://nnw.fm/1KMa3), Saskatchewan-based High Way 10 and parent company Flower Power Cannabis Pharms.

The High Way 10 acquisition could mark a tremendous leap forward for Choom and its shareholders. In a news release announcing the acquisition, Choom noted that High Way 10's initial 17,000 square foot facility is located on a 120-acre parcel of land, providing ample room for future expansion. As it stands, the facility is estimated to produce approximately 1,500 kg of dried cannabis per annum. According to Chris Bogart, president and CEO of Choom, "Upon completion of the retrofitting and compliance within the initial 17,000 sq. ft. building, Flower Power intends to submit its affirmation of readiness ("AOR") evidence package to Health Canada, which they hope will follow with the receipt of a cultivation license shortly thereafter."

While the company's portfolio also includes three late-stage licensed producer applicants based in British Columbia - bolstered by its entry into a definitive agreement to acquire Island Green Cure that was announced on April 19(http://nnw.fm/rl1V7) - High Way 10's presence in Saskatchewan immediately diversifies Choom's national presence at an important time. As previously noted, the Saskatchewan Liquor and Gaming Authority (SGLA) last month announced that the province would commence issuing retail permits. Because the SGLA has limited (http://nnw.fm/3CdnK) the number of retail permits to 51 for the first three years to ensure a controlled rollout, time of filing could play a major role in establishing the landscape of the local industry in coming years. In an April 17, 2018, news release, Choom provided (http://nnw.fm/F91gh) a retail overview, noting that it has secured nine retail locations in Alberta and seven in British Columbia, in addition to submitting 32 applications for retail permits in Saskatchewan.

"We have now established a footprint to position Choom™ as a leading private cannabis retailer in Western Canada," Bogart noted in a recent news release. "We will continue to pursue retail licensing opportunities across the country and remain committed to serving all Canadians in the coming consumer cannabis market. Choom's vision of delivering an elevated customer experience through our curated retail environments, with the creation of modern, stylish storefronts is well underway."

The Financial Impact of Regulation

As Choom enters the final phases of Health Canada's ACMPR permitting procedure, a complex seven-stage process (http://nnw.fm/Tc5J0)  that commonly takes more than a year to complete, it could be in line for considerable financial growth. Cronos Group, Inc. (TSX-V: CRON) (NASDAQ: CRON), operating as PharmaCan Capital Corp., acquired ACMPR licensed producer Peace Naturals Project Inc. in 2016, establishing itself as the first Canadian company to own and operate licensed producers in both Ontario and British Columbia. In January 2018, Cronos announced that Peace Naturals had obtained a dealer's license pursuant to the Controlled Drugs and Substances Act under Health Canada, enabling the company to export medical cannabis extracts, including concentrated oil and resin products, internationally. In the weeks that followed, Cronos became the first cannabis stock to list on the Nasdaq Global Market. Its U.S.-listed shares spiked from $3.31 in early December 2017 to a 52-week high of $9.40 in early March.

Share price increases related to key industry licensing and certification go well beyond Cronos to include many of the Canadian cannabis industry's most recognizable names. Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF), a leading diversified cannabis company boasting collaborations with cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds and Fortune 500 alcohol leader Constellation Brands, announced(http://nnw.fm/nMk5X) in early February that it had been conditionally selected by the Government of Manitoba to operate cannabis retail stores in the province. Since that announcement, Canopy's Canadian stock has rallied from C$26.50 in mid-February to a high of C$33.41 in mid-March. Canopy's Manitoba selection marks the second provincial retail agreement for the company, echoing the geographically diversified strategy currently being implemented by Choom Holdings.

Aphria, Inc. (TSX: APH) (OTC:QB APHQF) is another Canadian cannabis industry mainstay with an eye on geographical diversification as nationwide recreational legalization looms. In late January, Aphria announced (http://nnw.fm/5J0wR) its entry into an $826 million deal to acquire NuuverA, Inc., further demonstrating the fiscal value of Canada's vaunted licensed producer status. In August 2017, Nuuvera and Aphria entered a global strategic partnership initially focused on the Canadian market. In January of this year, the two firms announced a new offtake agreement for an additional 60,000 kg of cannabis production. In the days following that announcement, Aphria's Canada-listed shares built on recent achievements to reach a high of $C22.08, up from C$6.50 in October 2017.

Following this industry-wide trend, recreational and medical cannabis company Hiku Brands Company, Ltd. (CSE: HIKU) (OTC: DJACF) saw its Canadian shares climb to C$3.02 in mid-February following news that it was conditionally awarded (http://nnw.fm/Br06p)  one of four master retail licenses in Manitoba's highly competitive request for proposal process for the right to operate retail cannabis stores. This PPS was the highest achieved by Hiku since shortly after the close of the late-January merger between DOJA Cannabis Company Limited and TS Brandco Holdings Inc. that resulted in the newly-combined company, again reiterating the positive market reaction that has traditionally been associated with regulatory milestones in the competitive Canadian marijuana market.

A Burgeoning Market Opportunity

With a clear track record of PPS growth related to approvals from both Health Canada's ACMPR licensed producer program and provincial retail opportunities, the nation's impending legalization of recreational cannabis could present tremendous upside for investors with the foresight to capitalize on market trends. All told, cannabis industry tides are high, and, as Choom's website proudly outlines, it's a great time to 'Say Hello to Opportunity' (http://nnw.fm/5KfMw)

For more information on Choom Holdings, Inc., please visit Choom Holdings, Inc. (OTCQB: CHOOF) (CSE: CHOO)


READ ORIGINAL RELEASE BY NETWORK NEWS WIRE 



____________________________________________________________________

Please see full disclaimers at www.TheSeedInvestor.com applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimer

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. THESEEDINVESTOR.com (TSI) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. TSI receives payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. TSI retains any excess sums after expenses as its compensation. TheSeedInvestor.com and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. TheSeedInvestor.com may be paid for services using options or free-trading shares. TheSeedInvestor.com and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; TheSeedInvestor.com will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.

This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s),” “will,” “make,” “told,” “could,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein are forward-looking statements as defined in Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the company, or contained in this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements made herein except as required by law. Differences in results can be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements.” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. More information on the company may be found at http://www.sec.gov where readers can review all public filings submitted by the company. TheSeedInvestor.com is not a certified financial analyst or licensed in the securities industry in any manner. The information in this advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.